⌘K

Login Start Free

Home/Insiders/Malabre Richard C

MR

SEC Insider//CIK 0002007730

Malabre Richard C

CIK 00020077301 companyCAMBRIDGE, MA

Transactions

13

Companies

1

Filings

6

CIK

0002007730

Recent Transactions

13 trades

Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2026-02-02$1.39/sh−36,142→ 312,772 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2026-02-02$1.39/sh−13,382→ 299,390 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2026-01-30+79,000→ 348,914 total
Award
Akebia Therapeutics, Inc.$AKBA
Stock Option (Right to buy)
2026-01-30+119,000→ 119,000 total
Exercise/Conversion
Akebia Therapeutics, Inc.$AKBA
Stock Option (Right to buy)
2025-06-09−15,000→ 321,000 total
Exercise/Conversion
Akebia Therapeutics, Inc.$AKBA
Common Stock
2025-06-09$1.68/sh+15,000→ 281,914 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2025-06-09$4.01/sh−15,000→ 266,914 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2025-06-04$3.53/sh−13,334→ 266,914 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2025-02-03$2.10/sh−30,202→ 280,248 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2025-01-31+85,000→ 310,450 total
Award
Akebia Therapeutics, Inc.$AKBA
Stock Option (Right to buy)
2025-01-31+128,000→ 128,000 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2024-01-31+223,950→ 223,950 total
Award
Akebia Therapeutics, Inc.$AKBA
Stock Option (Right to buy)
2024-01-31+336,000→ 336,000 total

Companies

1

Akebia Therapeutics, Inc.
SVP, Chief Accounting Officer
$AKBA

Recent Filings

6

Address

C/O AKEBIA THERAPEUTICS, INC 245 FIRST ST.

CAMBRIDGE, MA, 02142

View on SEC.gov